Emma Guttman-Yassky, MD, PhD, discusses the long-term efficacy of deuruxolitinib in alopecia areata.
Emma Guttman-Yassky, MD, PhD
Advertisement
Articles by Emma Guttman-Yassky, MD, PhD
Emma Guttman, MD, PhD, discusses the promising potential of rocatinlimab in targeting the OX40-OX40 ligand pathway for atopic dermatitis treatment.
Emma Guttman-Yassky, MD, PhD, discusses promising hair regrowth results for alopecia areata treatments, emphasizing safety and rapid efficacy.
Advertisement
Latest Updated Articles
Deuruxolitinib in the Alopecia Areata Treatment Paradigm: Emma Guttman-Yassky, MDPublished: September 5th 2025 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Maternal, Child Mortality Higher in the US Compared With Majority of High-Income Countries
2
FDA Approves Second Generic Mifepristone Pill for Abortion
3
EASO Recommends Semaglutide, Tirzepatide for First-Line Obesity Therapy
4
Transforming Psychiatry: The Rise of Prescription Digital Therapeutics
5
